YOLFTbeta
Nanogroup SA

Nanogroup SA

NNG · WAR · Healthcare / Biotechnology

2.18PLN+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close2.18
Open2.17
Day Range1.98 – 2.20
52-Week Range2.18 – 3.20
Volume112.08K
Market Cap105.29M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.29
Dividend Yield0.00%
Beta0.54
50-Day Avg2.46
200-Day Avg2.49

About

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantation. NanoGroup S.A. was incorporated in 2016 and is based in Warsaw, Poland.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Przemyslaw Daniel Mazurek
  • Employees0
  • Headquartersul. Rakowiecka 36, Warsaw, Poland, 00-532, Poland
  • Websitehttps://nanogroup.eu

Leadership

  • Mr. Przemyslaw Daniel MazurekPresident of the Management Board
  • Mr. Piotr PietrzakVice President of the Management Board
  • Prof. Tomasz Adam CiachFounder & Member of the Management Board
  • Ms. Anna RedwanChief of Corporate Affairs & Communications

Financials

Income Statement

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue7.40K-40.80K110.29K351.83K687.51K492.49K139.55K2.02K2.10K0
Growth (%)---+170.33%+219.01%+95.41%-28.37%-71.66%-98.55%+4.01%-100.00%
Cost of Revenue6.01K58.40K86.85K25.55K18.25K31.18K185.90K95.78K81.04K46.56K111.47K
Gross Profit1.39K-58.40K-46.05K84.74K333.58K656.32K306.60K43.77K-79.02K-44.46K-111.47K
Gross Margin18.80%--112.87%76.83%94.81%95.46%62.25%31.36%-3913.67%-2117.10%-
Operating Expense635.78K892.60K1.97M2.49M2.04M3.92M10.89M825.90K7.82M5.13M10.28M
Operating Income-634.39K-951.01K-2.01M-2.41M-1.71M-3.26M-10.59M-782.14K-7.90M-5.18M-10.40M
Operating Margin-8569.34%--4935.76%-2181.02%-485.77%-474.76%-2149.55%-560.48%-391377.22%-246564.29%-
EBITDA-609.63K-784.61K-2.21M-2.64M-1.27M-5.06M-10.62M-719.95K-7.87M-5.19M-10.28M
EBITDA Margin-8234.88%--5411.04%-2395.80%-361.27%-735.40%-2157.40%-515.91%-389809.76%-246948.52%-
Net Income-716.18K-786.15K-2.01M-2.34M-1.54M-5.19M-10.01M-838.59K-7.89M-5.17M-9.45M
Net Income Margin-9674.13%--4935.10%-2125.87%-437.04%-754.79%-2031.60%-600.93%-390778.60%-246079.19%-
R&D------5.11M1.20M12.06M454.60K-
R&D as % of Total Revenue------1038.46%859.64%597200.10%21647.38%-
Interest Expense-20.91K24.31K19.33K51.38K31.80K52.19K1.36K5151.09K14
Interest Expense % of Total Revenue--59.58%17.53%14.60%4.63%10.60%0.98%25.51%51.90%-

Balance Sheet

Currency: PLN2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.19M5.78M19.45M22.61M27.04M26.38M30.04M20.30M19.20M8.63M19.94M40.55M
Total Liabilities1.44M505.16K6.70M8.44M11.51M13.07M11.27M11.94M11.42M3.47M4.01M20.57M
Total Equity-252.70K5.28M11.36M12.79M14.22M12.26M17.65M7.73M7.08M4.48M15.20M8.69M
Cash392.43K3.98M9.31M5.57M4.57M1.92M10.32M4.00M2.47M537.61K7.83M15.46M
Total Debt1.30M--69.44K45.55K652.12K612.51K285.31K139.17K---
Net Debt909.60K-3.98M-9.31M-5.51M-4.53M-1.27M-9.71M-3.71M-2.33M-537.61K-7.83M-15.46M

Cash Flow

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-126.11K-772.07K-2.60M-3.47M-1.58M-1.35M-3.20M-3.68M-4.76M-5.72M-8.80M
Investing Cash Flow-1.27M-2.07M-9.12M-5.86M-2.40M-2.01M-3.87M-806.87K-3.66M-4.58M-13.28M
Financing Cash Flow5.71M8.16M7.98M8.33M1.32M11.76M748.23K2.96M6.48M17.59M29.70M
Capital Expenditure02.08M9.12M5.86M2.82M2.17M3.87M806.87K75.92K191.86K1.17M
Free Cash Flow-126.11K-2.85M-11.72M-9.33M-4.40M-3.51M-7.07M-4.49M-4.84M-5.91M-9.97M
FCF to OCF100.00%369.07%451.03%268.62%278.81%260.71%221.00%121.90%101.59%103.36%113.29%

Earnings

Report DateDec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 31, 2023Sep 30, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------
EPS Actual-0.06-0.06-0.07-0.04-0.01-0.03-0.01-0.06-0.03-0.03-0.01-0.25-0.06-0.09-0.38-0.10-0.05-0.08-0.11-0.07-0.07-0.06-0.04-0.06-0.08-0.04-0.12-0.05-0.10
Surprise-----------------------------
Timing-----------------------------

Key Statistics & Ratios

Market Cap105.29M
Enterprise Value94.26M
Trailing P/E0.00
Forward P/E0.00
Price / Sales36.40
Price / Book3.44
EPS-0.29
Book Value0.726
Revenue (TTM)2.89M
Gross Profit (TTM)621.62K
EBITDA-11.54M
Profit Margin0.00%
Operating Margin-144.76%
Return on Equity-61.11%
Return on Assets-30.53%
Shares Outstanding42.63M
Shares Float25.27M
Beta0.54
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%